CDT Equity Inc. (CDT)

NCM – Цена в реальном времени. Валюта: USD

1.89

+0.02 (1.07%)

При закрытии: May 12, 2026, 4:00 PM EDT

1.98

+0.09 (4.76%)

До открытия: May 13, 2026, 5:24 AM EDT

07.05.2026

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new Substance of Matter (SOM) patent covering two established compounds within the cystic fibrosis market.

06.05.2026

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that AZD5904, a potent inhibitor of human Myeloperoxidase, originally licensed from AstraZeneca, has progressed into the Patent Cooperation Treaty (“PCT”) phase, marking a significant step in the globalisation of its intellectual property (IP) protection.

16.04.2026

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today provides a strategic update outlining its positioning as a multi-pathway value creation business spanning a pharmaceutical asset portfolio, proprietary solid-form intellectual property and artificial intelligence-driven indication discovery.

13.04.2026

What's Going On With CDT Equity Shares On Monday?

• CDT Equity stock is among today's top performers. What's behind CDT gains?

07.04.2026

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the publication of its research paper titled “PRISM: cross-species connectivity mapping of plant intervention and stress signatures for translational agriculture.

26.03.2026

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the filing of two new patent applications that further expand the Company's intellectual property portfolio surrounding tapinarof, a drug currently approved for the treatment of psoriasis and atopic dermatitis.

25.03.2026

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) announces that its board of directors has approved a 1-for-25 reverse stock split of the Company's common stock.

Видео

No Data

There is no data to display

Пресс-релизы

07.05.2026

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

06.05.2026

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

16.04.2026

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

07.04.2026

CDT Equity Inc. (CDT)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

CDT Equity Inc. (CDT)

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

What's Going On With CDT Equity Shares On Monday?

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

Видео

No Data

Пресс-релизы

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

What's Going On With CDT Equity Shares On Monday?

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

Видео

No Data

Пресс-релизы

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

Search stocks

CDT Equity Inc. (CDT)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

CDT Equity Inc. (CDT)

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

What's Going On With CDT Equity Shares On Monday?

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

Видео

No Data

Пресс-релизы

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

What's Going On With CDT Equity Shares On Monday?

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

Видео

No Data

Пресс-релизы

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI